华仁药业：华仁世纪集团计划减持公司股份不超过约3547万股

Group 1 - Core viewpoint: Huarun Pharmaceutical announced a share reduction plan by its major shareholder, Huarun Century Group, intending to reduce up to 3% of the company's total shares, approximately 35.47 million shares, within three months after the announcement [1] - Huarun Pharmaceutical's revenue composition for the first half of 2025 shows that the pharmaceutical industry accounts for 95.79% and the pharmaceutical commerce accounts for 4.21% [1] - The current market capitalization of Huarun Pharmaceutical is 4.3 billion yuan [2]